Pub Date : 2026-01-20DOI: 10.1186/s44158-026-00338-2
Etrusca Brogi, Camilla Cremonini, Marco Ceresoli, Fausto Catena, Angela Gurrado, Francesco Forfori, Lorenzo Ghiadoni, Ettore Melai, Massimo Sartelli, Federico Coccolini
Background: Intra-abdominal infections are complex and potentially life-threatening conditions frequently requiring intensive care admission and are associated with highly variable mortality driven by disease severity, host response, comorbidities, and antimicrobial resistance. Outcomes depend on timely diagnosis, effective surgical source control, appropriate antimicrobial therapy, and a coordinated multidisciplinary approach addressing both the infectious and systemic inflammatory components of the disease.
Material and method: This was a prospective, observational nationwide study. We included all adult patients admitted to the hospital with complicated abdominal infections requiring ICU admission. The aim of this study was to describe the epidemiology and outcomes of patients admitted to the hospital with intra-abdominal infections (IAIs) requiring an intensive care unit (ICU) admission in 23 Italian hospitals.
Results: A total of 784 patients admitted to the hospital with complicated IAIs requiring ICU admission were enrolled. Overall, in-hospital mortality among ICU patients was 23.9%. Septic shock (36.2%) and sepsis (35.9%) were the main reasons for ICU admission. Community-acquired infections accounted for 64.8% of cases, and adequate source control was achieved in 61.5% of patients. Re-operation was required in 21%. The most frequently isolated pathogens were Escherichia coli (23.1%), followed by Enterococcus spp. (15.4%). Empiric antibiotic therapy was prescribed in more than 80% of patients (median duration ranging from 8.1 to 19.3 days). Piperacillin-tazobactam was the most commonly used antibiotic. In multivariable logistic regression analysis, increasing age (OR 1.04 per year, 95% CI 1.03-1.06), immunosuppression (OR 1.99, 95% CI 1.09-3.66), serious cardiovascular disease (OR 1.91, 95% CI 1.20-3.05), re-operation (OR 2.30, 95% CI 1.34-3.96), inadequate source control (OR 0.39, 95% CI 0.22-0.71), peritonitis (OR 0.39, 95% CI 0.23-0.66), and healthcare-associated infections (OR 1.83, 95% CI 1.10-3.04) were independently associated with in-hospital mortality. Duration of antibiotic therapy, malignancy, and delay in initial intervention were not significantly associated with mortality.
Conclusion: Septic shock remains the leading cause of ICU admission in patients with IAIs. Patients with immunosuppression, serious cardiovascular comorbidities, requirement for re-operation, inadequate source control, peritonitis, and healthcare-associated infections were at significantly higher risk of in-hospital mortality. Overall, our study reinforces the multifactorial nature of mortality in critically ill patients with intra-abdominal infections, highlighting modifiable factors (source control, timely intervention) that can be targeted to improve outcomes.
背景:腹内感染是一种复杂且可能危及生命的疾病,通常需要重症监护,并与疾病严重程度、宿主反应、合并症和抗菌素耐药性驱动的高度可变死亡率相关。结果取决于及时的诊断,有效的手术源控制,适当的抗菌治疗,以及协调的多学科方法来解决疾病的感染性和系统性炎症成分。材料和方法:这是一项前瞻性、观察性的全国性研究。我们纳入了所有需要ICU住院的复杂腹部感染的成年患者。本研究的目的是描述意大利23家医院因腹内感染(IAIs)入院需要重症监护病房(ICU)的患者的流行病学和结局。结果:共纳入784例需要ICU住院的复杂IAIs患者。总体而言,ICU患者住院死亡率为23.9%。脓毒性休克(36.2%)和脓毒症(35.9%)是住院的主要原因。社区获得性感染占64.8%,61.5%的患者获得了充分的传染源控制。21%的患者需要再次手术。检出最多的病原菌为大肠杆菌(23.1%),其次为肠球菌(15.4%)。超过80%的患者使用经验性抗生素治疗(中位持续时间为8.1至19.3天)。哌拉西林-他唑巴坦是最常用的抗生素。在多变量logistic回归分析中,年龄增加(OR 1.04 /年,95% CI 1.03-1.06)、免疫抑制(OR 1.99, 95% CI 1.09-3.66)、严重心血管疾病(OR 1.91, 95% CI 1.20-3.05)、再手术(OR 2.30, 95% CI 1.34-3.96)、来源控制不充分(OR 0.39, 95% CI 0.22-0.71)、腹膜炎(OR 0.39, 95% CI 0.23-0.66)和医疗相关感染(OR 1.83, 95% CI 1.10-3.04)与院内死亡率独立相关。抗生素治疗的持续时间、恶性肿瘤和初始干预的延迟与死亡率无显著相关。结论:感染性休克仍是IAIs患者住院的主要原因。免疫抑制、严重心血管合并症、需要再次手术、源控制不充分、腹膜炎和医疗保健相关感染的患者住院死亡风险明显较高。总的来说,我们的研究强调了腹内感染危重患者死亡率的多因素性质,强调了可以有针对性地改善结果的可改变因素(来源控制,及时干预)。
{"title":"Epidemiology and outcome of intra-abdominal infections in intensive care unit in Italy from the Italian Register of complicated Intra-abdominal InfectionS-the IRIS study: a prospective observational nationwide study.","authors":"Etrusca Brogi, Camilla Cremonini, Marco Ceresoli, Fausto Catena, Angela Gurrado, Francesco Forfori, Lorenzo Ghiadoni, Ettore Melai, Massimo Sartelli, Federico Coccolini","doi":"10.1186/s44158-026-00338-2","DOIUrl":"https://doi.org/10.1186/s44158-026-00338-2","url":null,"abstract":"<p><strong>Background: </strong>Intra-abdominal infections are complex and potentially life-threatening conditions frequently requiring intensive care admission and are associated with highly variable mortality driven by disease severity, host response, comorbidities, and antimicrobial resistance. Outcomes depend on timely diagnosis, effective surgical source control, appropriate antimicrobial therapy, and a coordinated multidisciplinary approach addressing both the infectious and systemic inflammatory components of the disease.</p><p><strong>Material and method: </strong>This was a prospective, observational nationwide study. We included all adult patients admitted to the hospital with complicated abdominal infections requiring ICU admission. The aim of this study was to describe the epidemiology and outcomes of patients admitted to the hospital with intra-abdominal infections (IAIs) requiring an intensive care unit (ICU) admission in 23 Italian hospitals.</p><p><strong>Results: </strong>A total of 784 patients admitted to the hospital with complicated IAIs requiring ICU admission were enrolled. Overall, in-hospital mortality among ICU patients was 23.9%. Septic shock (36.2%) and sepsis (35.9%) were the main reasons for ICU admission. Community-acquired infections accounted for 64.8% of cases, and adequate source control was achieved in 61.5% of patients. Re-operation was required in 21%. The most frequently isolated pathogens were Escherichia coli (23.1%), followed by Enterococcus spp. (15.4%). Empiric antibiotic therapy was prescribed in more than 80% of patients (median duration ranging from 8.1 to 19.3 days). Piperacillin-tazobactam was the most commonly used antibiotic. In multivariable logistic regression analysis, increasing age (OR 1.04 per year, 95% CI 1.03-1.06), immunosuppression (OR 1.99, 95% CI 1.09-3.66), serious cardiovascular disease (OR 1.91, 95% CI 1.20-3.05), re-operation (OR 2.30, 95% CI 1.34-3.96), inadequate source control (OR 0.39, 95% CI 0.22-0.71), peritonitis (OR 0.39, 95% CI 0.23-0.66), and healthcare-associated infections (OR 1.83, 95% CI 1.10-3.04) were independently associated with in-hospital mortality. Duration of antibiotic therapy, malignancy, and delay in initial intervention were not significantly associated with mortality.</p><p><strong>Conclusion: </strong>Septic shock remains the leading cause of ICU admission in patients with IAIs. Patients with immunosuppression, serious cardiovascular comorbidities, requirement for re-operation, inadequate source control, peritonitis, and healthcare-associated infections were at significantly higher risk of in-hospital mortality. Overall, our study reinforces the multifactorial nature of mortality in critically ill patients with intra-abdominal infections, highlighting modifiable factors (source control, timely intervention) that can be targeted to improve outcomes.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1186/s44158-026-00344-4
Lara Gianesello, Alessio Caccioppola, Andrea Meli, Rossella Marcucci, Anna Maria Gori, Matteo Innocenti, Roberto Civinini, Stefano Romagnoli, Giacomo Grasselli, Mauro Panigada
Background: Deep vein thrombosis (DVT) is a frequent complication in elderly patients undergoing surgery for proximal femoral fractures. Identifying early coagulation and viscoelastic changes may help to personalize thromboprophylaxis strategies. This study evaluated the temporal evolution of coagulation and ROTEM parameters and explored whether baseline values and early changes could predict the development of asymptomatic DVT.
Methods: We conducted a prospective observational study including patients ≥ 80 years undergoing surgical repair of proximal femoral fractures. Conventional coagulation tests and ROTEM were performed at admission (T0) and on postoperative day 3 (T3). Compression ultrasonography was used to screen for DVT on day 5 (T5). Longitudinal changes were assessed with linear mixed-effects models.
Results: Among 40 enrolled patients, 7 (17.5%) developed asymptomatic DVT. Platelet count was consistently higher in DVT patients (baseline: 275.0 ± 47.1 vs 186.5 ± 54.9 × 109/L; p < 0.001). ROTEM revealed increased EXTEM maximum clot firmness (67.6 ± 1.7 vs 62.2 ± 5.7 mm; p = 0.024) and shorter clot formation time (92.0 ± 9.3 vs 116.1 ± 32.0 s; p = 0.041). Fibrinogen levels diverged over time: while baseline values were comparable, DVT patients showed progressive increases (+ 43.7 mg/dL/day) versus reductions in non-DVT patients (-9.5 mg/dL/day), yielding significant differences at T3 (525.3 ± 177.0 vs 372.1 ± 177.8 mg/dL; p = 0.015). FIBTEM-MCF did not differ between groups. A baseline platelet count ≥ 277 × 109/L predicted DVT with 71% sensitivity and 97% specificity (AUC 0.896).
Conclusion: In elderly patients with femoral fractures, asymptomatic DVT was associated with elevated baseline platelet counts, enhanced clot firmness, and progressive fibrinogen elevation over time. These findings suggest multifaceted hypercoagulable abnormalities with temporal monitoring potentially superior to single-timepoint assessments for DVT prediction.
背景:深静脉血栓形成(DVT)是老年股骨近端骨折手术患者的常见并发症。确定早期凝血和粘弹性变化可能有助于个性化血栓预防策略。本研究评估凝血和ROTEM参数的时间演变,并探讨基线值和早期变化是否可以预测无症状DVT的发展。方法:我们进行了一项前瞻性观察研究,纳入≥80岁接受股骨近端骨折手术修复的患者。入院时(T0)和术后第3天(T3)分别进行常规凝血试验和ROTEM。第5天(T5)采用压缩超声筛查DVT。采用线性混合效应模型评估纵向变化。结果:在40例入组患者中,7例(17.5%)发生无症状DVT。血小板计数在DVT患者中持续较高(基线:275.0±47.1 vs 186.5±54.9 × 109/L; p9 /L预测DVT的敏感性为71%,特异性为97% (AUC 0.896)。结论:在老年股骨骨折患者中,无症状DVT与基线血小板计数升高、凝块硬度增强以及纤维蛋白原随时间的进行性升高有关。这些发现表明,多面高凝异常与时间监测可能优于单时间点评估DVT预测。
{"title":"Platelet count, fibrinogen and ROTEM® parameters predict deep vein thrombosis in elderly patients with femoral fracture.","authors":"Lara Gianesello, Alessio Caccioppola, Andrea Meli, Rossella Marcucci, Anna Maria Gori, Matteo Innocenti, Roberto Civinini, Stefano Romagnoli, Giacomo Grasselli, Mauro Panigada","doi":"10.1186/s44158-026-00344-4","DOIUrl":"https://doi.org/10.1186/s44158-026-00344-4","url":null,"abstract":"<p><strong>Background: </strong>Deep vein thrombosis (DVT) is a frequent complication in elderly patients undergoing surgery for proximal femoral fractures. Identifying early coagulation and viscoelastic changes may help to personalize thromboprophylaxis strategies. This study evaluated the temporal evolution of coagulation and ROTEM parameters and explored whether baseline values and early changes could predict the development of asymptomatic DVT.</p><p><strong>Methods: </strong>We conducted a prospective observational study including patients ≥ 80 years undergoing surgical repair of proximal femoral fractures. Conventional coagulation tests and ROTEM were performed at admission (T0) and on postoperative day 3 (T3). Compression ultrasonography was used to screen for DVT on day 5 (T5). Longitudinal changes were assessed with linear mixed-effects models.</p><p><strong>Results: </strong>Among 40 enrolled patients, 7 (17.5%) developed asymptomatic DVT. Platelet count was consistently higher in DVT patients (baseline: 275.0 ± 47.1 vs 186.5 ± 54.9 × 10<sup>9</sup>/L; p < 0.001). ROTEM revealed increased EXTEM maximum clot firmness (67.6 ± 1.7 vs 62.2 ± 5.7 mm; p = 0.024) and shorter clot formation time (92.0 ± 9.3 vs 116.1 ± 32.0 s; p = 0.041). Fibrinogen levels diverged over time: while baseline values were comparable, DVT patients showed progressive increases (+ 43.7 mg/dL/day) versus reductions in non-DVT patients (-9.5 mg/dL/day), yielding significant differences at T3 (525.3 ± 177.0 vs 372.1 ± 177.8 mg/dL; p = 0.015). FIBTEM-MCF did not differ between groups. A baseline platelet count ≥ 277 × 10<sup>9</sup>/L predicted DVT with 71% sensitivity and 97% specificity (AUC 0.896).</p><p><strong>Conclusion: </strong>In elderly patients with femoral fractures, asymptomatic DVT was associated with elevated baseline platelet counts, enhanced clot firmness, and progressive fibrinogen elevation over time. These findings suggest multifaceted hypercoagulable abnormalities with temporal monitoring potentially superior to single-timepoint assessments for DVT prediction.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1186/s44158-025-00334-y
Nicola Di Fazio, Christian Zanza, Yaroslava Longhitano, Antonio Voza, Roberto Balagna, Sabino Mosca, Pietro Balagna, Riccardo Rossignoli, Sara Cerenzia, Giuseppe Bertozzi, Aniello Maiese, Paola Frati, Raffaele La Russa
In recent years, artificial intelligence (AI) has become an increasingly prominent player in emergency medicine, offering innovative tools to enhance the early diagnosis of acute conditions. This systematic review explores how AI, particularly through machine learning (ML) and deep learning (DL), is transforming the way physicians and healthcare professionals respond to high-stakes clinical scenarios. The evidence gathered shows that smart algorithms are capable of detecting complex patterns in clinical, diagnostic, and laboratory data, patterns that may even elude expert clinicians, especially under the high-pressure environment of the emergency room. From acute coronary syndrome to stroke, from sepsis to respiratory failure, AI has demonstrated impressive predictive power and provides real, practical support in risk stratification, triage optimization, and faster diagnosis. Equally important is its role in automated medical image analysis, which enables quicker and more accurate diagnostic decisions, offering real-time support for clinicians. However, the widespread adoption of these technologies also brings significant challenges: the need for algorithmic transparency, the necessity of earning the trust of healthcare providers, and the sensitive ethical issues related to patient data privacy. To overcome these barriers, it is essential to involve healthcare professionals in the development and implementation of AI technologies-ensuring their clinical expertise complements the analytical power of these new tools. Targeted training programs and large-scale validation studies are critical steps for ensuring the safe and effective use of AI. Ultimately, this review confirms that AI holds great promise as a catalyst for a more efficient, timely, and patient-centered approach to emergency medicine.
{"title":"Artificial intelligence for early diagnosis in emergency department.","authors":"Nicola Di Fazio, Christian Zanza, Yaroslava Longhitano, Antonio Voza, Roberto Balagna, Sabino Mosca, Pietro Balagna, Riccardo Rossignoli, Sara Cerenzia, Giuseppe Bertozzi, Aniello Maiese, Paola Frati, Raffaele La Russa","doi":"10.1186/s44158-025-00334-y","DOIUrl":"10.1186/s44158-025-00334-y","url":null,"abstract":"<p><p>In recent years, artificial intelligence (AI) has become an increasingly prominent player in emergency medicine, offering innovative tools to enhance the early diagnosis of acute conditions. This systematic review explores how AI, particularly through machine learning (ML) and deep learning (DL), is transforming the way physicians and healthcare professionals respond to high-stakes clinical scenarios. The evidence gathered shows that smart algorithms are capable of detecting complex patterns in clinical, diagnostic, and laboratory data, patterns that may even elude expert clinicians, especially under the high-pressure environment of the emergency room. From acute coronary syndrome to stroke, from sepsis to respiratory failure, AI has demonstrated impressive predictive power and provides real, practical support in risk stratification, triage optimization, and faster diagnosis. Equally important is its role in automated medical image analysis, which enables quicker and more accurate diagnostic decisions, offering real-time support for clinicians. However, the widespread adoption of these technologies also brings significant challenges: the need for algorithmic transparency, the necessity of earning the trust of healthcare providers, and the sensitive ethical issues related to patient data privacy. To overcome these barriers, it is essential to involve healthcare professionals in the development and implementation of AI technologies-ensuring their clinical expertise complements the analytical power of these new tools. Targeted training programs and large-scale validation studies are critical steps for ensuring the safe and effective use of AI. Ultimately, this review confirms that AI holds great promise as a catalyst for a more efficient, timely, and patient-centered approach to emergency medicine.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":"6 1","pages":"7"},"PeriodicalIF":3.1,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12814581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1186/s44158-026-00339-1
Je Min Suh, Laurence Weinberg, Nattaya Raykateeraroj, Kaden Tran, David Pilcher, Dong-Kyu Lee
Background: With the growing numbers of nonagenarians and centenarians admitted to intensive care, clinicians face complex decisions regarding care appropriateness and intensity. Prognostic tools such as APACHE III, SOFA, and the Australia and New Zealand Risk of Death (ANZROD) model are widely used, yet their validity in very old patients remains uncertain given the influence of frailty, multimorbidity, and age-related physiological changes. In this study, we evaluated and compared the performance of APACHE III, its Risk of Death score, SOFA, and ANZROD in a large binational cohort of ICU-admitted nonagenarians and centenarians, assessing discrimination, calibration, and predictive utility for short- and long-term mortality using AUROC, standardized mortality ratios, and decision curve analysis.
Methods: We conducted a multicenter retrospective cohort study of 40,910 patients aged 90 years and older who were admitted to ICUs across Australia and New Zealand from 2010 to 2024. Discrimination was assessed using time-dependent area under the receiver operating characteristic curve (AUROC). Calibration was evaluated with standardized mortality ratios (SMRs), and clinical utility was examined using decision curve analysis (DCA) across ICU, hospital, 1-month, 6-month, and 1-year mortality outcomes.
Results: ANZROD consistently showed the highest discriminative ability, with AUROCs of 0.870 for ICU mortality and 0.768 for 1-month mortality. APACHEIII ROD and APACHE III followed, while SOFA had the lowest AUROCs across all timepoints. SMR analysis revealed overestimation of short term and underestimation of long term mortality by all models. ANZROD had the best calibration for hospital mortality. DCA showed ANZROD provided greater net benefit than the other scores at clinically relevant thresholds.
Conclusions: In this large binational cohort of over 40,000 nonagenarian and centenarian ICU patients, ANZROD outperformed APACHE III and SOFA in short-term mortality prediction, but all models showed poor calibration and declining discrimination over longer horizons. Current scores remain useful for benchmarking but are limited for individual decision-making, underscoring the need for age-specific prognostic tools that integrate frailty, function, and geriatric priorities.
{"title":"Validity of ICU prognostic risk stratification tools in the oldest patients: a comparative analysis of clinical scores in a multicenter binational cohort.","authors":"Je Min Suh, Laurence Weinberg, Nattaya Raykateeraroj, Kaden Tran, David Pilcher, Dong-Kyu Lee","doi":"10.1186/s44158-026-00339-1","DOIUrl":"https://doi.org/10.1186/s44158-026-00339-1","url":null,"abstract":"<p><strong>Background: </strong>With the growing numbers of nonagenarians and centenarians admitted to intensive care, clinicians face complex decisions regarding care appropriateness and intensity. Prognostic tools such as APACHE III, SOFA, and the Australia and New Zealand Risk of Death (ANZROD) model are widely used, yet their validity in very old patients remains uncertain given the influence of frailty, multimorbidity, and age-related physiological changes. In this study, we evaluated and compared the performance of APACHE III, its Risk of Death score, SOFA, and ANZROD in a large binational cohort of ICU-admitted nonagenarians and centenarians, assessing discrimination, calibration, and predictive utility for short- and long-term mortality using AUROC, standardized mortality ratios, and decision curve analysis.</p><p><strong>Methods: </strong>We conducted a multicenter retrospective cohort study of 40,910 patients aged 90 years and older who were admitted to ICUs across Australia and New Zealand from 2010 to 2024. Discrimination was assessed using time-dependent area under the receiver operating characteristic curve (AUROC). Calibration was evaluated with standardized mortality ratios (SMRs), and clinical utility was examined using decision curve analysis (DCA) across ICU, hospital, 1-month, 6-month, and 1-year mortality outcomes.</p><p><strong>Results: </strong>ANZROD consistently showed the highest discriminative ability, with AUROCs of 0.870 for ICU mortality and 0.768 for 1-month mortality. APACHEIII ROD and APACHE III followed, while SOFA had the lowest AUROCs across all timepoints. SMR analysis revealed overestimation of short term and underestimation of long term mortality by all models. ANZROD had the best calibration for hospital mortality. DCA showed ANZROD provided greater net benefit than the other scores at clinically relevant thresholds.</p><p><strong>Conclusions: </strong>In this large binational cohort of over 40,000 nonagenarian and centenarian ICU patients, ANZROD outperformed APACHE III and SOFA in short-term mortality prediction, but all models showed poor calibration and declining discrimination over longer horizons. Current scores remain useful for benchmarking but are limited for individual decision-making, underscoring the need for age-specific prognostic tools that integrate frailty, function, and geriatric priorities.</p><p><strong>Trial registration: </strong>ACTRN12625000775415 (23/07/2025).</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1186/s44158-026-00340-8
Rachel Eshima McKay, Merlín D Larson
Objective: We examined the relationship between modeled opioid concentration and quantitative pupillary measures during remifentanil infusion sequences with particular attention to the "light-off" (LO) reflex.
Methods: Ten volunteer subjects were recruited to undergo two 10-min remifentanil infusion protocols. Pupillary unrest in ambient light (PUAL) and LO were measured at baseline and every 2.5 min during the first 10-min infusion-25-min recovery sequence, and after a wash-out period, the Neurological Pupillary index (NPi) and LO were measured during an identical infusion-recovery sequence. We tested proportional change in each parameter from baseline as indicators of dynamic opioid effect.
Results: On average, remifentanil decreased both LO dilation and PUAL by > 85%, decreased pupil diameter by > 48%, but did not significantly alter the NPi. Hypoxia occurred in 15/16 sequences. LO and PUAL both showed excellent discrimination between high-toxic versus zero-moderate opioid effect. In contrast to PUAL and LO, the scaled pupillary light reflex measurement (NPi) was not altered by opioids.
Conclusion: LO and PUAL were robust indicators of opioid effect and provided equivalent estimates of respiratory depression risk in our healthy awake subjects. Compared with PUAL, LO offers the advantage of being intuitive and easily derived at the bedside without need for specialized software.
Significance: Measurement of the pupillary LO reflex with a portable pupillometer provides a simple, discriminating measure of opioid effect. Remifentanil blocks the pupillary LO reflex.
{"title":"The effect of opioids on the light-off pupillary reflex.","authors":"Rachel Eshima McKay, Merlín D Larson","doi":"10.1186/s44158-026-00340-8","DOIUrl":"10.1186/s44158-026-00340-8","url":null,"abstract":"<p><strong>Objective: </strong>We examined the relationship between modeled opioid concentration and quantitative pupillary measures during remifentanil infusion sequences with particular attention to the \"light-off\" (LO) reflex.</p><p><strong>Methods: </strong>Ten volunteer subjects were recruited to undergo two 10-min remifentanil infusion protocols. Pupillary unrest in ambient light (PUAL) and LO were measured at baseline and every 2.5 min during the first 10-min infusion-25-min recovery sequence, and after a wash-out period, the Neurological Pupillary index (NPi) and LO were measured during an identical infusion-recovery sequence. We tested proportional change in each parameter from baseline as indicators of dynamic opioid effect.</p><p><strong>Results: </strong>On average, remifentanil decreased both LO dilation and PUAL by > 85%, decreased pupil diameter by > 48%, but did not significantly alter the NPi. Hypoxia occurred in 15/16 sequences. LO and PUAL both showed excellent discrimination between high-toxic versus zero-moderate opioid effect. In contrast to PUAL and LO, the scaled pupillary light reflex measurement (NPi) was not altered by opioids.</p><p><strong>Conclusion: </strong>LO and PUAL were robust indicators of opioid effect and provided equivalent estimates of respiratory depression risk in our healthy awake subjects. Compared with PUAL, LO offers the advantage of being intuitive and easily derived at the bedside without need for specialized software.</p><p><strong>Significance: </strong>Measurement of the pupillary LO reflex with a portable pupillometer provides a simple, discriminating measure of opioid effect. Remifentanil blocks the pupillary LO reflex.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":"25"},"PeriodicalIF":3.1,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15DOI: 10.1186/s44158-025-00333-z
Mina Adolf Helmy, Kerlous Adolf Helmy, Rana M Zaki, Sara A Khatab, Sherif Alaa Embaby, Reham Amin Kaddah, Mohamed Ahmed Shamma, Lydia Magdy Milad
Background: Spinal anesthesia-induced hypotension is a common complication during cesarean delivery, often requiring vasopressor support, and is associated with maternal discomfort. Caffeine, a central nervous system stimulant with well-documented cardiovascular effects, may provide a simple adjunct to enhance hemodynamic stability. We aimed to evaluate the efficacy of a single preoperative 200 mg oral caffeine dose in reducing the incidence and severity of hypotension following spinal anesthesia in healthy patients undergoing elective cesarean delivery.
Methods: In this randomized controlled trial, 90 patients classified as ASA II and scheduled for elective cesarean delivery under spinal anesthesia were assigned to receive either 200 mg oral caffeine or a placebo 30 min before the procedure. Hemodynamic parameters, the incidence and severity of hypotension, baseline and 60 min post-administration serum caffeine levels, ephedrine requirements, incidence of postoperative nausea and vomiting, and post-dural puncture headache were recorded and analyzed.
Results: Caffeine administration significantly reduced the incidence of hypotension (9% vs. 33%, p < 0.05). Severe hypotension was not observed in the caffeine group. Patients in the caffeine group demonstrated greater hemodynamic stability, with a delayed onset of hypotension and reduced ephedrine requirements. No significant differences were observed in the incidence of bradycardia, tachycardia, or reactive hypertension. Neonatal outcomes were comparable between the groups. Additionally, caffeine was associated with lower rates of postoperative nausea and vomiting (2% vs. 20%) and post-dural puncture headache (2% vs. 16%) at 24 h.
Conclusion: Preoperative administration of 200 mg oral caffeine is a cost-effective strategy for reducing spinal anesthesia-induced hypotension, the incidence of postoperative nausea and vomiting, and post-dural puncture headache in healthy patients undergoing elective cesarean delivery. These findings support further investigation of the role of caffeine as an adjunct in obstetric anesthesia.
Trial registration: The study was registered by the principal investigator (M. Helmy) at ClinicalTrials.gov under the identifier NCT07076654 on July 11, 2025.
背景:脊髓麻醉引起的低血压是剖宫产的常见并发症,通常需要血管加压剂支持,并与产妇不适有关。咖啡因是一种中枢神经系统兴奋剂,具有良好的心血管作用,可能提供一种简单的辅助剂来增强血液动力学稳定性。我们的目的是评估术前单次口服200 mg咖啡因在减少健康患者择期剖宫产脊髓麻醉后低血压的发生率和严重程度方面的疗效。方法:在这项随机对照试验中,90例ASA II级并计划在脊髓麻醉下择期剖宫产的患者在手术前30分钟接受200 mg口服咖啡因或安慰剂。记录并分析血流动力学参数、低血压发生率及严重程度、给药后基线及60分钟血清咖啡因水平、麻黄碱需氧量、术后恶心呕吐发生率及硬脑膜穿刺后头痛。结果:咖啡因可显著降低低血压的发生率(9% vs 33%)。结论:术前口服200 mg咖啡因可降低择期剖宫产的健康患者腰麻所致低血压、术后恶心呕吐和硬膜穿刺后头痛的发生率。这些发现支持进一步研究咖啡因在产科麻醉中的辅助作用。试验注册:该研究由首席研究员(M. Helmy)于2025年7月11日在ClinicalTrials.gov网站注册,注册号为NCT07076654。
{"title":"Caffeine before cesarean delivery: a novel preventive strategy against spinal hypotension, a double blind placebo-controlled trial.","authors":"Mina Adolf Helmy, Kerlous Adolf Helmy, Rana M Zaki, Sara A Khatab, Sherif Alaa Embaby, Reham Amin Kaddah, Mohamed Ahmed Shamma, Lydia Magdy Milad","doi":"10.1186/s44158-025-00333-z","DOIUrl":"10.1186/s44158-025-00333-z","url":null,"abstract":"<p><strong>Background: </strong>Spinal anesthesia-induced hypotension is a common complication during cesarean delivery, often requiring vasopressor support, and is associated with maternal discomfort. Caffeine, a central nervous system stimulant with well-documented cardiovascular effects, may provide a simple adjunct to enhance hemodynamic stability. We aimed to evaluate the efficacy of a single preoperative 200 mg oral caffeine dose in reducing the incidence and severity of hypotension following spinal anesthesia in healthy patients undergoing elective cesarean delivery.</p><p><strong>Methods: </strong>In this randomized controlled trial, 90 patients classified as ASA II and scheduled for elective cesarean delivery under spinal anesthesia were assigned to receive either 200 mg oral caffeine or a placebo 30 min before the procedure. Hemodynamic parameters, the incidence and severity of hypotension, baseline and 60 min post-administration serum caffeine levels, ephedrine requirements, incidence of postoperative nausea and vomiting, and post-dural puncture headache were recorded and analyzed.</p><p><strong>Results: </strong>Caffeine administration significantly reduced the incidence of hypotension (9% vs. 33%, p < 0.05). Severe hypotension was not observed in the caffeine group. Patients in the caffeine group demonstrated greater hemodynamic stability, with a delayed onset of hypotension and reduced ephedrine requirements. No significant differences were observed in the incidence of bradycardia, tachycardia, or reactive hypertension. Neonatal outcomes were comparable between the groups. Additionally, caffeine was associated with lower rates of postoperative nausea and vomiting (2% vs. 20%) and post-dural puncture headache (2% vs. 16%) at 24 h.</p><p><strong>Conclusion: </strong>Preoperative administration of 200 mg oral caffeine is a cost-effective strategy for reducing spinal anesthesia-induced hypotension, the incidence of postoperative nausea and vomiting, and post-dural puncture headache in healthy patients undergoing elective cesarean delivery. These findings support further investigation of the role of caffeine as an adjunct in obstetric anesthesia.</p><p><strong>Trial registration: </strong>The study was registered by the principal investigator (M. Helmy) at ClinicalTrials.gov under the identifier NCT07076654 on July 11, 2025.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":"12"},"PeriodicalIF":3.1,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1186/s44158-025-00327-x
Martina Tosi, Erika Roat, Emanuela Biagioni, Filippo Bondi, Giovanni Chierego, Stefano De Julis, Marta Talamonti, Paolo Magistri, Gian Piero Guerrini, Stefano Busani, Stefano Di Sandro, Fabrizio Di Benedetto, Massimo Girardis
Background: Robotic liver transplantation (LT) is a recent advancement in minimally invasive surgery; however, perioperative and anaesthetic management have not yet been described in detail. This study aimed to characterise the anaesthetic course of fully robotic LT and compare the perioperative outcomes with those of propensity score-matched open LT.
Methods: We conducted an observational, retrospective, single-centre study at Modena University Hospital. Fully robotic LTs were compared with matched open LTs. Matching was performed in a 1:1 ratio according to age, sex, BMI, year of transplantation, indication, presence of hepatocellular carcinoma, and MELD score.
Results: Eighteen robotic and 457 open LTs were initially identified; after matching, 11 robotic and 11 open cases were included in the study. In the robotic group, the operative time was longer (p < 0.05) and associated (p < 0.05) with higher lactate levels, greater norepinephrine requirement, and larger blood loss, requiring a larger use of blood components compared to standard open surgery. Postoperatively, extubation timing, cardiovascular, respiratory, and liver function recovery, and renal complications were comparable between the groups. Pain control required less opioids (p < 0.05) and ICU (p > 0.05) and hospital stay (p < 0.05) were lower in robotic than in open surgery.
Conclusions: Fully robotic LT is associated with longer operative times, greater blood loss, and increased haemodynamic demands. Despite these challenges, postoperative recovery, particularly hospital stay, appears to be favourable. Larger multicentre studies are needed to validate these findings and refine the anaesthetic strategies.
{"title":"Anaesthesiological and perioperative aspects of fully robotic versus open liver transplantation: a matched case-control study.","authors":"Martina Tosi, Erika Roat, Emanuela Biagioni, Filippo Bondi, Giovanni Chierego, Stefano De Julis, Marta Talamonti, Paolo Magistri, Gian Piero Guerrini, Stefano Busani, Stefano Di Sandro, Fabrizio Di Benedetto, Massimo Girardis","doi":"10.1186/s44158-025-00327-x","DOIUrl":"10.1186/s44158-025-00327-x","url":null,"abstract":"<p><strong>Background: </strong>Robotic liver transplantation (LT) is a recent advancement in minimally invasive surgery; however, perioperative and anaesthetic management have not yet been described in detail. This study aimed to characterise the anaesthetic course of fully robotic LT and compare the perioperative outcomes with those of propensity score-matched open LT.</p><p><strong>Methods: </strong>We conducted an observational, retrospective, single-centre study at Modena University Hospital. Fully robotic LTs were compared with matched open LTs. Matching was performed in a 1:1 ratio according to age, sex, BMI, year of transplantation, indication, presence of hepatocellular carcinoma, and MELD score.</p><p><strong>Results: </strong>Eighteen robotic and 457 open LTs were initially identified; after matching, 11 robotic and 11 open cases were included in the study. In the robotic group, the operative time was longer (p < 0.05) and associated (p < 0.05) with higher lactate levels, greater norepinephrine requirement, and larger blood loss, requiring a larger use of blood components compared to standard open surgery. Postoperatively, extubation timing, cardiovascular, respiratory, and liver function recovery, and renal complications were comparable between the groups. Pain control required less opioids (p < 0.05) and ICU (p > 0.05) and hospital stay (p < 0.05) were lower in robotic than in open surgery.</p><p><strong>Conclusions: </strong>Fully robotic LT is associated with longer operative times, greater blood loss, and increased haemodynamic demands. Despite these challenges, postoperative recovery, particularly hospital stay, appears to be favourable. Larger multicentre studies are needed to validate these findings and refine the anaesthetic strategies.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":"24"},"PeriodicalIF":3.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Ventilator-associated pneumonia (VAP) is a preventable complication of invasive mechanical ventilation (IMV) with a significant healthcare impact. Early risk prediction is crucial, but current models lack real-time adaptability. This study develops a real-time VAP prediction model using machine learning and high-resolution EHR data from the MIMIC-III database.
Methods: We analyzed 3523 ICU stays (3204 patients) from MIMIC-III, including adults who received IMV for at least 48 h. VAP was labeled based on microbiological cultures and antibiotic initiation. A real-time ensemble model of XGBoost regressors was developed to predict time to VAP onset, incorporating vital signs, ventilator data, and lab results. Two static classifiers (24 h and 48 h) were also compared.
Results: VAP occurred in 595 ICU stays (16.89%), with an incidence rate of 23.77 per 1000 IMV-days. Median VAP onset was 113.5 h post-IMV. The real-time model outperformed static models with a C-index of 0.68, AUROC of 0.71, and AUPRC of 0.36. It provided a median lead time of 53 h before VAP onset, with key predictors including temperature, respiratory rate, and minute ventilation.
Conclusion: We present a real-time VAP prediction model that outperforms static classifiers, providing actionable lead time for proactive microbiological surveillance. The model enables risk stratification for enhanced monitoring and, when clinically indicated, timely targeted antimicrobial therapy. Future work will focus on multicenter prospective validation and integration into ICU workflows to assess clinical utility and impact on patient outcomes.
{"title":"Real-time prediction of ventilator-associated pneumonia onset in ICU: development of a dynamic machine learning model.","authors":"Simone Zappalà, Lucrezia Rovati, Francesca Alfieri, Andrea Ancona, Amedeo Guzzardella, Giacomo Grasselli, Vittorio Scaravilli","doi":"10.1186/s44158-025-00313-3","DOIUrl":"10.1186/s44158-025-00313-3","url":null,"abstract":"<p><strong>Background: </strong>Ventilator-associated pneumonia (VAP) is a preventable complication of invasive mechanical ventilation (IMV) with a significant healthcare impact. Early risk prediction is crucial, but current models lack real-time adaptability. This study develops a real-time VAP prediction model using machine learning and high-resolution EHR data from the MIMIC-III database.</p><p><strong>Methods: </strong>We analyzed 3523 ICU stays (3204 patients) from MIMIC-III, including adults who received IMV for at least 48 h. VAP was labeled based on microbiological cultures and antibiotic initiation. A real-time ensemble model of XGBoost regressors was developed to predict time to VAP onset, incorporating vital signs, ventilator data, and lab results. Two static classifiers (24 h and 48 h) were also compared.</p><p><strong>Results: </strong>VAP occurred in 595 ICU stays (16.89%), with an incidence rate of 23.77 per 1000 IMV-days. Median VAP onset was 113.5 h post-IMV. The real-time model outperformed static models with a C-index of 0.68, AUROC of 0.71, and AUPRC of 0.36. It provided a median lead time of 53 h before VAP onset, with key predictors including temperature, respiratory rate, and minute ventilation.</p><p><strong>Conclusion: </strong>We present a real-time VAP prediction model that outperforms static classifiers, providing actionable lead time for proactive microbiological surveillance. The model enables risk stratification for enhanced monitoring and, when clinically indicated, timely targeted antimicrobial therapy. Future work will focus on multicenter prospective validation and integration into ICU workflows to assess clinical utility and impact on patient outcomes.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":"23"},"PeriodicalIF":3.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145959314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1186/s44158-026-00337-3
Marco Piastra, Ivonne Portaccio, Arianna Dondi, Enzo Picconi, Tony Christian Morena, Maria Cristina Mondardini, Donato Rigante, Giorgia Spinazzola, Gabriella De Rosa, Giorgio Conti
Background: Idiopathic systemic capillary leak syndrome (SCLS), or Clarkson syndrome, is a rare disorder characterized by increased capillary permeability causing fluid leakage into interstitial spaces. SCLS remains underdiagnosed in both adults and children due to its resemblance to septic shock, with particularly limited pediatric data available.
Methods: We conducted a retrospective analysis of six pediatric patients with seven SCLS episodes diagnosed in two Italian PICUs over a ten-year period.
Results: Patients aged 4-10 years presented with hypovolemic shock and the characteristic triad of hypovolemia, hemoconcentration, and hypoalbuminemia without albuminuria. No monoclonal gammopathy was observed. Viral infections (75%, predominantly influenza) were identified as triggers. Common complications included rhabdomyolysis (100%), compartment syndrome (100%), acute kidney injury (71.4%), and cardiac involvement (71.4%). Cardiothoracic index measurements showed significant elevation during acute phases (mean 58% ± 1%) with reduction after treatment (mean 51% ± 1%). Mean hospitalization was 20 days (12 in PICU). One patient died from refractory ventricular fibrillation, another experienced recurrence.
Conclusions: Pediatric SCLS represents a severe condition with distinctive characteristics compared to adult cases, including absence of monoclonal gammopathy, frequent viral triggers, and universal complications of rhabdomyolysis and compartment syndrome. Early recognition using our proposed diagnostic red flags can facilitate prompt intervention and improve outcomes.
{"title":"Idiopathic systemic capillary leak syndrome and related shock in PICU: an underdiagnosed disease?","authors":"Marco Piastra, Ivonne Portaccio, Arianna Dondi, Enzo Picconi, Tony Christian Morena, Maria Cristina Mondardini, Donato Rigante, Giorgia Spinazzola, Gabriella De Rosa, Giorgio Conti","doi":"10.1186/s44158-026-00337-3","DOIUrl":"10.1186/s44158-026-00337-3","url":null,"abstract":"<p><strong>Background: </strong>Idiopathic systemic capillary leak syndrome (SCLS), or Clarkson syndrome, is a rare disorder characterized by increased capillary permeability causing fluid leakage into interstitial spaces. SCLS remains underdiagnosed in both adults and children due to its resemblance to septic shock, with particularly limited pediatric data available.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of six pediatric patients with seven SCLS episodes diagnosed in two Italian PICUs over a ten-year period.</p><p><strong>Results: </strong>Patients aged 4-10 years presented with hypovolemic shock and the characteristic triad of hypovolemia, hemoconcentration, and hypoalbuminemia without albuminuria. No monoclonal gammopathy was observed. Viral infections (75%, predominantly influenza) were identified as triggers. Common complications included rhabdomyolysis (100%), compartment syndrome (100%), acute kidney injury (71.4%), and cardiac involvement (71.4%). Cardiothoracic index measurements showed significant elevation during acute phases (mean 58% ± 1%) with reduction after treatment (mean 51% ± 1%). Mean hospitalization was 20 days (12 in PICU). One patient died from refractory ventricular fibrillation, another experienced recurrence.</p><p><strong>Conclusions: </strong>Pediatric SCLS represents a severe condition with distinctive characteristics compared to adult cases, including absence of monoclonal gammopathy, frequent viral triggers, and universal complications of rhabdomyolysis and compartment syndrome. Early recognition using our proposed diagnostic red flags can facilitate prompt intervention and improve outcomes.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":"22"},"PeriodicalIF":3.1,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882570/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145947089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-09DOI: 10.1186/s44158-025-00329-9
Luigi Vetrugno, Cristian Deana, Enrico Boero, Daniele Guerino Biasucci, Sean Scott, Flavio Bassi, Corrado Fiore, Yoshihisa Morita, Sabina Caciolli, Marinella Zanierato, Elena Giovanna Bignami, Stefano Romagnoli
Transesophageal echocardiography (TEE) has emerged as a transformative tool in the management of cardiac arrest, offering significant advantages over traditional transthoracic echocardiography (TTE) by enabling continuous, high-resolution cardiac imaging during resuscitation. Initially used in operating rooms before 2000, TEE expanded into emergency departments (EDs), intensive care units (ICUs), and even prehospital settings. Its superior imaging capability during cardiopulmonary resuscitation (CPR) supports rapid diagnosis, optimization of compression quality, and more accurate rhythm assessment, including the differentiation between asystole and fine ventricular fibrillation. TEE has been shown to influence intra-arrest clinical decision-making in up to 78% of cases, often revealing pathologies-such as aortic dissection or cardiac rupture-not detected by TTE. Importantly, TEE aids in identifying reversible causes of cardiac arrest, guiding high-quality CPR by assessing left ventricular outflow tract (LVOT) obstruction, and shortening the duration of pulse checks. It also may play a role in extracorporeal CPR (ECPR) and organ donation procedures, particularly in cannulation and monitoring during extracorporeal membrane oxygenation (ECMO) and normothermic regional perfusion (NRP). TEE use is feasible and safe during cardiac arrest, with high insertion success rates and minimal complications when performed by trained personnel. While cardiologists, anesthesiologists, and intensivists traditionally perform TEE, simplified training protocols now enable emergency physicians to safely and effectively deploy TEE in critical settings. Protocols such as "POCUS-TEE" may promote rapid acquisition of essential views, facilitating broader implementation. Despite the potential benefits, several barriers to widespread adoption remain. These include the availability of equipment, limitations in training, and concerns regarding the safety of the probe during defibrillation. Resuscitation guidelines recommend removing the transesophageal echocardiogram (TEE) probe, or at least insulating it, as a precaution during defibrillation. TEE is particularly valuable when TTE proves inadequate, such as in obese or mechanically ventilated patients. In conclusion, TEE might enhance the quality and precision of resuscitation in cardiac arrest and has the potential to improve survival and neurological outcomes in selected cases. Its broader adoption hinges on institutional support, streamlined protocols, operator training, and further research to validate its impact on patient-centered outcomes. As technology advances and clinical integration improves, TEE may become a cornerstone of advanced life support in both in-hospital and out-of-hospital settings.
{"title":"Transesophageal echocardiography in cardiac arrest: why, how, when, and where in clinical practice.","authors":"Luigi Vetrugno, Cristian Deana, Enrico Boero, Daniele Guerino Biasucci, Sean Scott, Flavio Bassi, Corrado Fiore, Yoshihisa Morita, Sabina Caciolli, Marinella Zanierato, Elena Giovanna Bignami, Stefano Romagnoli","doi":"10.1186/s44158-025-00329-9","DOIUrl":"10.1186/s44158-025-00329-9","url":null,"abstract":"<p><p>Transesophageal echocardiography (TEE) has emerged as a transformative tool in the management of cardiac arrest, offering significant advantages over traditional transthoracic echocardiography (TTE) by enabling continuous, high-resolution cardiac imaging during resuscitation. Initially used in operating rooms before 2000, TEE expanded into emergency departments (EDs), intensive care units (ICUs), and even prehospital settings. Its superior imaging capability during cardiopulmonary resuscitation (CPR) supports rapid diagnosis, optimization of compression quality, and more accurate rhythm assessment, including the differentiation between asystole and fine ventricular fibrillation. TEE has been shown to influence intra-arrest clinical decision-making in up to 78% of cases, often revealing pathologies-such as aortic dissection or cardiac rupture-not detected by TTE. Importantly, TEE aids in identifying reversible causes of cardiac arrest, guiding high-quality CPR by assessing left ventricular outflow tract (LVOT) obstruction, and shortening the duration of pulse checks. It also may play a role in extracorporeal CPR (ECPR) and organ donation procedures, particularly in cannulation and monitoring during extracorporeal membrane oxygenation (ECMO) and normothermic regional perfusion (NRP). TEE use is feasible and safe during cardiac arrest, with high insertion success rates and minimal complications when performed by trained personnel. While cardiologists, anesthesiologists, and intensivists traditionally perform TEE, simplified training protocols now enable emergency physicians to safely and effectively deploy TEE in critical settings. Protocols such as \"POCUS-TEE\" may promote rapid acquisition of essential views, facilitating broader implementation. Despite the potential benefits, several barriers to widespread adoption remain. These include the availability of equipment, limitations in training, and concerns regarding the safety of the probe during defibrillation. Resuscitation guidelines recommend removing the transesophageal echocardiogram (TEE) probe, or at least insulating it, as a precaution during defibrillation. TEE is particularly valuable when TTE proves inadequate, such as in obese or mechanically ventilated patients. In conclusion, TEE might enhance the quality and precision of resuscitation in cardiac arrest and has the potential to improve survival and neurological outcomes in selected cases. Its broader adoption hinges on institutional support, streamlined protocols, operator training, and further research to validate its impact on patient-centered outcomes. As technology advances and clinical integration improves, TEE may become a cornerstone of advanced life support in both in-hospital and out-of-hospital settings.</p>","PeriodicalId":73597,"journal":{"name":"Journal of Anesthesia, Analgesia and Critical Care (Online)","volume":" ","pages":"18"},"PeriodicalIF":3.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12882177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145936583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}